Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 359.53 M439.92 M407.11 M426.35 M421.37 M 1.69 B Research & development 331.67 M359.62 M371.25 M364.9 M380.79 M 1.48 B Operating income -35.48 M-4.33 M58.52 M301.17 M-80.29 M 275.07 M Non-Operating Income, Total 4.52 M10.96 M144 K-109 K-994 K 10 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 00000 0 Unusual income/expense 4.52 M10.96 M144 K-109 K-994 K 10 M Pretax income -3.67 M34.65 M87.2 M327.71 M-63.5 M 386.06 M Equity in earnings ————— — Taxes -12.59 M-4.1 M-4.91 M50.64 M10.09 M 51.71 M Non-controlling/minority interest ————— — After tax other income/expense -760 K-16.13 M6.45 M2.6 M6.89 M -197 K Net income before discontinued operations 8.92 M38.76 M92.11 M277.07 M-73.59 M 334.35 M Discontinued operations ————— — Net income 8.92 M38.76 M92.11 M277.07 M-73.59 M 334.35 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 9.99 M43.38 M102.94 M309.77 M73.59 M 529.68 M Basic earnings per share (Basic EPS) 0.010.060.140.41-0.12 0.49 Diluted earnings per share (Diluted EPS) 0.010.060.130.41-0.12 0.48 Average basic shares outstanding 593.72 M594.28 M595.32 M593.47 M556.91 M — Diluted shares outstanding 689.36 M689.6 M691.25 M687.77 M556.91 M — EBITDA -29.63 M1.76 M65.72 M307.18 M-71.47 M 303.2 M EBIT -35.48 M-4.33 M58.52 M301.17 M-80.29 M 275.07 M Cost of revenue 199.27 M203.01 M212.32 M226.92 M238.55 M 880.8 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 5.85 M6.09 M7.21 M6.01 M8.83 M 28.13 M